Edurant Dosage & Drug Information

Concise Prescribing Info

Contents

Rilpivirine HCl

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

In combination w/ other antiretroviral medicinal products for HIV-1 infection in antiretroviral treatment-naïve adult patients & ped patients 12-17 yr w/ viral load ≤100,000 HIV-1 RNA copies/mL at start of therapy.

Dosage/Direction for Use

Adult & ped patient ≥12 to 17 yr weighing at least 32 kg 25 mg once daily. Patient concomitantly receiving rifabutin Increase dose to 50 mg once daily then decrease to 25 mg once daily when co-administration is stopped.

Administration

Should be taken with food: Take w/ meals for optimal absorption.

Contraindications

Hypersensitivity. Co-administration w/ drugs which induce CYP3A enzymes or increase gastric pH.

MIMS Class

Antivirals

ATC Classification

J05AG05 - rilpivirine ; Belongs to the class of non-nucleoside reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.

Regulatory Classification

POM

Presentation/Packing

Form

Edurant FC tab 25 mg

Packing/Price

1's

Edurant

rilpivirine

Manufacturer:

Janssen-Cilag Pty Ltd